Panagora Asset Management’s Wave Life Sciences WVE Stock Holding History

Panagora Asset Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-65,543	Closed	-$213K	–	1561
2022 Q2	$213K	Buy	+65,543	New	+$126K	﹤0.01%	1395
2021 Q3	–	Sell	-973	Closed	-$6K	–	2400
2021 Q2	$6K	Sell	973 -52	-5%	-$340	﹤0.01%	2451
2021 Q1	$6K	Hold	1,025	–	–	﹤0.01%	2558
2020 Q4	$8K	Buy	+1,025	New	+$8.6K	﹤0.01%	2352
2019 Q4	–	Sell	-2,278	Closed	-$47K	–	2585
2019 Q3	$47K	Buy	+2,278	New	+$52.2K	﹤0.01%	1980

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Panagora Asset Management's WVE Position: Q3 2022 in Review

Panagora Asset Management sold out of Wave Life Sciences (WVE) in Q3 2022, closing a stake of 65,543 shares — an estimated $213K sold.

Panagora Asset Management first reported a position in WVE in Q3 2019 and held it in 5 quarters. The position peaked at $213K in Q2 2022. 61 funds tracked by Wall St. Rank hold WVE as of Q3 2022.

Panagora Asset Management reported no remaining Wave Life Sciences position as of Q3 2022 after selling out during the quarter.
Panagora Asset Management sold 65,543 Wave Life Sciences shares in Q3 2022, an estimated $213K.
Panagora Asset Management first reported a position in Wave Life Sciences in Q3 2019 and held it in 5 quarters.
Panagora Asset Management's Wave Life Sciences position peaked at $213K in Q2 2022.
61 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2022.

Based on Panagora Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.